belantamab mafodotin

1 Drug classified under this active ingredient

IgG1 kappa immunoglobulin, Monoclonal Antibody. belantamab mafodotin 100 mg.
Vial.  Pwder for. sol. for inf. 1 X 100 mg
In combin. with bortezomib and dexamethasone, admin. once every 3 weeks with a starting dose of 2.5 mg/kg. Combined with pomalidomide and dexamethasone, admin. once every 4 weeks with a starting dose of 2.5 mg/kg in Cycle 1. From Cycle 2 and onwards, dose at 1.9 mg/kg. See full prescription info.
in adlts for the tmt. of relapsed or refract. multiple myeloma:
• in combin. with bortezomib and dexamethasone in pts who have received at least one prior ther. • in combin. with pomalidomide and dexamethasone in pts who have received at least one prior ther. incl. lenalidomide.
C/I:  Hypersens.